All News #Library
Biotech
Huidagene Announces First Patient Dosed In Multinational Ph 1/2 Trial Of Hg004
01 Nov 2023 //
PR NEWSWIRE
Huidagene Receives FDA Rare Pediatric Disease Designation For Hg004
07 Aug 2023 //
PR NEWSWIRE
HuidaGene Appoints New Members to the Scientific Advisory Board
10 Apr 2023 //
PR NEWSWIRE
HuidaGene Receives Orphan Drug Designation for Gene Therapy of Blindness
03 Apr 2023 //
PR NEWSWIRE

Market Place
Sourcing Support